Jeon, D.; Jun, I.; Lee, H.K.; Park, J.; Kim, B.-R.; Ryu, K.; Yoon, H.; Kim, T.-i.; Namkung, W.
Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice. Int. J. Mol. Sci. 2022, 23, 5206.
https://doi.org/10.3390/ijms23095206
AMA Style
Jeon D, Jun I, Lee HK, Park J, Kim B-R, Ryu K, Yoon H, Kim T-i, Namkung W.
Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice. International Journal of Molecular Sciences. 2022; 23(9):5206.
https://doi.org/10.3390/ijms23095206
Chicago/Turabian Style
Jeon, Dongkyu, Ikhyun Jun, Ho K. Lee, Jinhong Park, Bo-Rahm Kim, Kunhi Ryu, Hongchul Yoon, Tae-im Kim, and Wan Namkung.
2022. "Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice" International Journal of Molecular Sciences 23, no. 9: 5206.
https://doi.org/10.3390/ijms23095206
APA Style
Jeon, D., Jun, I., Lee, H. K., Park, J., Kim, B.-R., Ryu, K., Yoon, H., Kim, T.-i., & Namkung, W.
(2022). Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice. International Journal of Molecular Sciences, 23(9), 5206.
https://doi.org/10.3390/ijms23095206
